Method for screening traditional Chinese medicines influencing drug resistance of escherichia coil generating ESBLs (extended spectyum beta lactamase)
A technology of Escherichia coli and drug resistance, which is applied in the field of traditional Chinese medicine screening that affects drug resistance of ESBLs-producing Escherichia coli, can solve the problems of narrowing the screening range of traditional Chinese medicine, difficulty in judging the accuracy of results, and slow screening speed, so as to avoid sterilization The conflict between the effect and drug resistance reversal effect, the effect of expanding the type and scope of screening, and the convenience of operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] The screening of Zeilan traditional Chinese medicine that has drug resistance reversal effect on TEM-producing Escherichia coli is carried out according to the following steps:
[0021] (1) Use the conventional ESBLs-producing Escherichia coli primary screening method to screen the enzyme-producing strains, and then use the PCR amplification method to confirm that the ESBLs-producing type is TEM type, and save it for future use;
[0022] (2) In the first batch of 96-well plates, the sub-inhibitory concentration of E. coli strains resistant to ESBLs was determined by using the double-dilution method of micro-tubes, and the minimum inhibitory concentration of western medicine was determined. The western medicine was Amo Penicillin, ciprofloxacin, norfloxacin, levofloxacin, clinfloxacin, sulfamethoxine sodium, gatifloxacin, and florfenicol.
[0023] (3) According to the sub-inhibitory concentration of Eupatorium obtained in step (2), after adding the sub-inhibitory concent...
Embodiment 2
[0031] The screening of the traditional Chinese medicine that has drug-resistant reversal effect on CTX-M-producing Escherichia coli is carried out according to the following steps:
[0032] (1) The enzyme-producing strains were screened by conventional ESBLs-producing Escherichia coli screening method, and then confirmed by PCR amplification that the ESBLs-producing type was CTX-M, and stored for future use;
[0033] (2) On the first batch of 96-well plates, the sub-inhibitory concentration of Escherichia coli strains resistant to ESBLs and the minimum inhibitory concentration of Western medicine were determined by using the double-dilution method of micro test tubes, and the western medicine was Amo Xilin, Norfloxacin, Levofloxacin, Shigaojing, Clinfloxacin, Sulfamethoxine Sodium, Gatifloxacin, and Florfenicol.
[0034] (3) According to the sub-inhibitory concentration of baubing obtained in step (2), after adding the sub-inhibitory concentration of baubing in the culture me...
Embodiment 3
[0042] The screening of Escherichia coli traditional Chinese medicine with drug-resistant reversal effect on TEM and CTX-M Escherichia coli is carried out according to the following steps:
[0043] (1) The enzyme-producing strains were screened by conventional ESBLs-producing E. coli screening methods, and then confirmed by PCR amplification that the types of ESBLs produced were TEM and CTX-M, and stored for future use;
[0044] (2) On the first batch of 96-well plates, the sub-inhibitory concentration of Escherichia coli against drug-resistant ESBLs-producing Escherichia coli strains was determined by using the micro-tube double dilution method, and the minimum inhibitory concentration of western medicine was determined. The western medicine is cephalosporin Trixone sodium, amoxicillin, amikacin, doxycycline, ciprofloxacin, and norfloxacin.
[0045] (3) According to the sub-inhibitory concentration of P. chinensis obtained in step (2), after adding the sub-inhibitory concentr...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com